Skip to main content
Rohit Loomba on Muck Rack

Rohit Loomba

San Diego
As seen in: Nature, Wiley, Wiley Online Library, Cardiology in the Young, ScienceDirect, Gut Journal, MDPI, PNAS, The Conversation, JAMA (The Journal of the American Medical Association) and
Liver doctor/Professor of Medicine/clinical trial design Phase 1-4/inventor/drug developer/life's goal to find a cure for liver fibrosis & NASH.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rohit

Contact Rohit, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Letter on ‘Network Meta-Analysis: Comparison of Pharmacological Therapies in Compensated MASH Cirrhosis for Fibrosis Regression and MASH Resolution’. Authors' Reply

|
By Matheus Souza, Rohit Loomba
| Wiley Online Library Verified
Handling Editor: Grace Wong MASH metabolic dysfunction-associated steatohepatitis NIT non-invasive test NMA network meta-analysis RCT randomised controlled trial We appreciate the constructive commentary by Soni and Díaz on our network meta-analysis (NMA) evaluating pharmacological therapies for compensated metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis [1, 2].
Open in Who Shared Issue with article?

The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease

|
By Mohammad S. Siddiqui, Mark Van Natta, Margery A Connelly, Jeanne M. Clark, Brent A Neuschwander-Tetri, Anna Mae Diehl, Srinivasan Dasarathy, Rohit Loomba, Naga P. Chalasani, Kris V. Kowdley, Bilal Hameed, Laura Wilson, Katherine P. Yates, Patricia H. Belt, David E Kleiner, Cynthia Behling, James Tonascia, Arun J Sanyal
| Nature Verified
Abstract We evaluated the prognostic performance of the metabolic vulnerability index (MVX), reflective of inflammation and amino acid dysmetabolism, in a cohort (n = 1613) with the full histological spectrum of MASLD.
Open in Who Shared Issue with article?

A Digital Model to Explain the Necessity of Prostaglandin E1 After Balloon Atrial Septostomy in D-Transposition of the Great Arteries

|
By Fabio Savorgnan, Saul Flores Verified, Rohit Loomba
| preprints.org
You are already at the latest version Objective: Patients with D-Transposition of the Great Arteries (TGA) often require prostaglandin E1 (PGE) even after balloon atrial septostomy (BAS). This study builds a computer simulation that analyzes whether or not elevated pulmonary vascular resistance (PVR) could explain the profound hypoxemia seen in some patients after PGE discontinuation.
Open in Who Shared Issue with article?
See all 162 licensed articles (164 Total)